340B Drug Discount Program

Medicare Outpatient Expenditures Estimated to Grow $6.5B

The calendar year 2023 Outpatient Prospective Payment System (OPPS) final rule, issued Nov. 1, 2022, by the Centers for Medicare and Medicaid Services estimates that Medicare expenditures under OPPS will increase by $6.5 billion, relative to estimated current year payments, based on changes in the final rule. Key provisions are:  

Court Rules HHS Must Restore Full 340B Payments to Hospitals for Rest of 2022

On Sept. 28, a federal district court ruled that the Department of Health & Human Services (HHS) must immediately halt the department’s cuts to outpatient reimbursement rates for the remainder of 2022 for certain hospitals that participate in the 340B Drug Pricing Program. HHS will begin restoring a payment rate of average sales price plus […]

CHA Comments on OPPS Proposed Rule

CHA submitted comments on the calendar year (CY) 2023 outpatient prospective payment system (OPPS) proposed rule. In the letter, CHA raises concerns about the inadequate proposed market basket update and asks CMS to use alternative sources of data that better reflect input price inflation experienced by providers to calculate the CY 2023 market basket update. […]